NeuroCovid: The Neurological Aftermath of Covid-19

Streamed on:
1K

This expert-led conference brings together leading voices in research and frontline medicine. Through their collective expertise, we will examine how COVID-19 has reshaped our understanding of the brain, and address the urgent steps needed to improve diagnostics and patient outcomes. Join us for an in-depth exploration of the latest science and clinical insights that are shaping the future of NeuroCovid care.

Agenda

Introductions
Speaker presentations
Q&A with panellists after each speaker
Open forum discussion
Close
Keynote Speakers – 20 min presentations each

Dr Abdul Mannan Baig: Physician, Neurology research Topic: To be confirmed
Kevin McCairn, PhD: Neurology research Topic: The biochemical and structural properties of amyloidogenic fibrin aggregates
Dr Diane Counce: Neurologist Topic: On the front line of NeuroCovid: NeuroQuant and clinical case studies
Panellists

Charles Rixey, MA, MBA
Dr Phillip Triantos
Roundtable Discussion (Informal session following formal part of conference)

Moderator: Dr Philip McMillan
Speakers and Panellists
Audience

This conference is suitable for:

Medical professionals and researchers
Integrative and functional medicine practitioners
Patients and advocates seeking science-based insights
Anyone interested in post-viral illness and vaccine-related health challenges

About Vejon Health Limited

At Vejon Health, we want to improve the resilience and quality of life of current and future generations by improving the understanding and management of complex diseases. We take a unique approach to medical research, and focus on identifying the primary cause of diseases such as COVID-19 and long Covid.

Join on Substack:
https://philipmcmillan.substack.com/

Join on Patreon:
https://patreon.com/VejonHealth

#COVID19 #CovidVaccines

FREE and Paid Courses Available!
https://mcmillanresearch.com/mr-education/

Watch videos at McMillan Research:
https://mcmillanresearch.com/media/

#covid #medicine #research

Loading 6 comments...